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Abstract
Objective To evaluate the effectiveness on glycaemic control of a training
programme in consultation skills for paediatric diabetes teams.
Design Pragmatic cluster randomised controlled trial.
Setting 26 UK secondary and tertiary care paediatric diabetes services.
Participants 79 healthcare practitioners (13 teams) trained in the
intervention (359 young people with type 1 diabetes aged 4-15 years
and their main carers) and 13 teams allocated to the control group (334
children and their main carers).
Intervention Talking Diabetes programme, which promotes shared
agenda setting and guiding communication style, through flexible menu
of consultation strategies to support patient led behaviour change.
Main outcome measures The primary outcome was glycated
haemoglobin (HbA1c) level one year after training. Secondary outcomes
were clinical measures (hypoglycaemic episodes, body mass index,
insulin regimen), general and diabetes specific quality of life, self reported
and proxy reported self care and enablement, perceptions of the diabetes
team, self reported and carer reported importance of, and confidence
in, undertaking diabetes self management measured over one year.
Analysis was by intention to treat. An integrated process evaluation
included audio recording a sample of 86 routine consultations to assess
skills shortly after training (intervention group) and at one year follow-up
(intervention and control group). Two key domains of skill assessment
were use of the guiding communication style and shared agenda setting.
Results 660/693 patients (95.2%) provided blood samples at follow-up.
Training diabetes care teams had no effect on HbA1c levels (intervention
effect 0.01, 95% confidence interval −0.02 to 0.04, P=0.5), even after
adjusting for age and sex of the participants. At follow-up, trained staff
(n=29) were more capable than controls (n=29) in guiding (difference in
means 1.14, P<0.001) and agenda setting (difference in proportions
0.45, 95% confidence interval 0.22 to 0.62). Although skills waned over
time for the trained practitioners, the reduction was not significant for
either guiding (difference in means −0.33, P=0.128) or use of agenda
setting (difference in proportions −0.20, −0.42 to 0.05). 390 patients
(56%) and 441 carers (64%) completed follow-up questionnaires. Some
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Overview of secondary outcomes
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Research
RESEARCHaspects of diabetes specific quality of life improved in controls: reduced
problems with treatment barriers (mean difference −4.6, 95% confidence
interval −8.5 to −0.6, P=0.03) and with treatment adherence (−3.1, −6.3
to −0.01, P=0.05). Short term ability to cope with diabetes increased in
patients in intervention clinics (10.4, 0.5 to 20.4, P=0.04). Carers in the
intervention arm reported greater excitement about clinic visits (1.9, 1.05
to 3.43, P=0.03) and improved continuity of care (0.2, 0.1 to 0.3, P=0.01).
Conclusions Improving glycaemic control in children attending specialist
diabetes clinics may not be possible through brief, team-wide training
in consultation skills.
Trial registration Current Controlled Trials ISRCTN61568050.
Introduction
Diabetesisthethirdmostcommonchronicdiseaseinchildhood,
with at least 13.5 new cases per 100 000 children annually in
the United Kingdom.
1 2 The control of blood glucose is an
importantriskfactorforcomplications
3andisaffectedbyinsulin
treatment, lifestyle, and psychosocial and educational
influences.
4 However, management targets are realised in only
a small proportion of children.
5 6 Psychoeducational
interventions, including education integrated into routine care
andcontinuedparentalinvolvementthatencouragesselfefficacy
in adolescents have resulted in modest improvements in blood
glucose control in young people with diabetes.
7-9 Current
evidenceispredominantlyavailablefromtheUnitedStatesand
may be context dependent. There is also little evidence about
theeffectofpsychosocialoreducationalinterventionsinvolving
youngerchildren.Furthermore,althoughtrialshaveshownsome
recent methodological improvements, most have been
underpoweredtodetectclinicallyimportantchangesinglycated
haemoglobin (HbA1c) levels.
7 8 Evidence from the United
Kingdom on the effectiveness of psychoeducational
interventions alone in improving glycaemic control in children
is limited.
9 The authors of a systematic review concluded that
although there was some evidence that theoretically based
interventions are more effective, many interventions evaluated
so far have not been explicitly theory based.
7 10
Although clear evidence for the superiority of one
psychoeducationalapproachoveranotherislacking,anefficacy
studyofmotivationalinterviewinginchildhooddiabetes
9found
a beneficial effect on HbA1c levels. Motivational interviewing
promotes prioritising patient preference and supports patient
autonomy. It is, however, unclear whether large numbers of
practitioners delivering this intervention in a routine clinical
setting (as opposed to delivery by specialist therapists) is
effective.
11 12
ThedeliveryofdiabetescaretochildrenintheUnitedKingdom
is usually located in secondary care and the multidisciplinary
teams include paediatricians with expertise in childhood
diabetes, nurse specialists, dietitians, child psychologists,
podiatrists,andsocialworkers.Only21%ofservices,however,
report integrated specialist psychologist support.
13 Therefore
the responsibility of psychoeducational support for affected
children and their families most often remains with other
members of the healthcare team. Evidence to inform decisions
about whether to invest in a limited number of specialist
psychoeducational practitioners or to train whole teams in
psychoeducational consulting skills is lacking. The whole team
approach has the benefit of increasing reach, whereas the
intensity offered by specialist practitioners may enhance
effectiveness but for fewer patients.
Therefore an important gap in the evidence base supporting
diabetes care in children was the question of the effectiveness
of broadly applicable, theoretically based, team wide training
in psychoeducational consulting skills that encourages parental
involvement and that promotes self efficacy in adolescents.
Given this lack of evidence, we carried out a phase of
intervention development and feasibility assessment. This
showed that practitioners in UK secondary care paediatric
diabetes teams recognised the importance of dealing with
psychosocial needs but lacked the confidence and training in
consultation skills to address them.
14 15 Practitioners reported
challenges in engaging families in the process of care and that
available training was remote from actual clinical practice.
16
Family members of affected children reported feeling that
attendance at a clinic seemed to serve the needs of clinicians
ratherthanthoseofthechildrenandtheirparentsandsometimes
marginalised the children themselves.
17 Children and teenagers
with diabetes indicated that they wanted a more positive
approach from teams, which took greater account of the
constraintsoftheirlifeworld.Ourresearchteamhostedaseries
ofdevelopmentalworkshopstointegratefindingsfromreviews
oftheevidencebasewithperspectivesfromlayandprofessional
stakeholders: the Stakeholder Advisory Group.
18
The Talking Diabetes training programme was developed from
this process. It focused on shared setting of agendas and a
flexiblestyleofcommunicationbypractitioners.Theprogramme
was informed by motivational interviewing and promoted a
guiding consulting style to explore and support opportunities
tochangehealthrelatedbehaviours,whichmayleadtoimproved
metabolic control. The programme provided a menu of
consultation strategies, and practitioners were trained to use it
through a combination of web based training and two
workshops. We evaluated the effectiveness of training teams
usingtheTalkingDiabetesprogrammeinimprovingglycaemic
control and the quality of life of young people with diabetes.
Wehypothesisedthatpractitionerstrainedusingtheprogramme
would support young people to manage their diabetes better
resulting in a lower mean HbA1c level than in young people
cared for by untrained teams.
Methods
We present a pragmatic, cluster randomised controlled trial of
the Talking Diabetes programme within UK clinical practice.
Themethodshavebeendescribedindetailpreviously.
19Briefly,
the evaluation phase of the Talking Diabetes training
programme, known as the DEPICTED (the Development and
Evaluation of a Psychosocial Intervention in Children and
Teenagers Experiencing Diabetes) study was set in UK
secondarycare.Aneconomicanalysiswascarriedoutalongside
the trial and is reported elsewhere.
20
Centres and participants
Centreswereidentifiedandapproachedduringthedevelopment
phaseofthestudyusinganaugmentedspecialistregisterofUK
services.
15Ofthecentresexpressinganinterest,30wereinvited
to participate based on entry criteria (minimum eligible clinic
list size of 40, at least one paediatrician with an interest in
diabetes,andadiabetesspecialistnurse).Familieswereeligible
for participation if their child had type 1 diabetes diagnosed no
less than 12 months earlier, was aged between 4 and 15 years,
was not expected to leave the care of the participating centre
for the duration of the study, and if both child and one parent
or carer were able to complete study materials and provide
adequate informed consent. Children were not eligible if they
were not being looked after by either their parent or their
guardian,hadacomorbiditythatwaslikelytoaffecttheirHbA1c
measurement, were in receipt of psychiatric or psychological
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RESEARCHtherapy, or were clinically judged to be vulnerable owing to
social circumstances or an existing medical condition.
Recruitment and centre randomisation
A locally employed research nurse identified and approached
eligiblefamiliesbeforerandomisationbycentre.Foreachcentre,
a random sample of 40 children was selected by the trial team
using anonymised clinic lists with the aim of obtaining 30
recruited children. Families were approached by letter and
recruited after written informed consent from both parent and
child (assent in the case of younger patients). Recruitment and
randomisationwereundertakeninthreeblocksbutwithpatients
in each centre being approached en bloc by letter.
21 Each
participating centre was allocated to undertake training in the
TalkingDiabetesprogrammeeitherbefore(interventiongroup)
or at the end (control group) of a one year study period.
Randomisation was optimally balanced for patient list size.
22
The first block of centres recruited was randomised so that
intervention training could begin. Subsequent blocks of centres
wererandomised,maintainingthebalanceforlistsize.Thetrial
statisticiancarriedoutrandomisationindependentofcentreand
child recruitment. A statistician independent of the trials unit
allocated the intervention and control centres to the final
sequence.Theallocationswerethenpassedtothetrialmanager
and concealed from centres until training was arranged for
intervention centres.
Intervention
Thetrainingprogrammeaimedtopreparepractitionersformore
constructive consultations about behaviour change by placing
patients at the centre of their own consultation and enhancing
engagement with their own healthcare.
19 Training emphasised
shared setting of agendas and a guiding communication style,
aswellasdiscretestrategiesandskillsdrawnfrommotivational
interviewing practice. Role played interactions modelled how
the strategies could be flexibly deployed in routine
consultations.
23 24 The shared agenda setting was supported by
a physical tool (3T: TimeToTalk, produced by Cardiff
University), which was a pad of sheets with images of young
peopleandencircleddiscussiontopicsincludingadequateblank
space and empty circles for the young people and their carers
to record and review agenda items with clinic staff. Training of
practitioners was delivered through web based modules, which
comprised formal didactic content (about 1.5 hours) and
interactive components. Additionally, two team based day
workshops, delivered about two weeks apart by two trainers,
provided opportunities to review and practice intervention
strategies and skills. After the second workshop, practitioners
wereabletoreportconsultationsonlineandtoreceivefeedback
from the trainer team. The bespoke and manualised training
programme was constructed around three case studies
representing common clinical challenges in paediatric diabetes
care. Once trained, practitioners were expected to conduct
modified consultations with their patients for the remainder of
the 12 month study period, as part of otherwise routine care.
Primary and secondary outcomes (measured
at patient level)
The primary outcome measure was HbA1c level measured at
baselineandatoneyearusingcapillarybloodsamplescollected
by local research nurses and assayed at a single central
laboratory. Values were reported after adjustment against the
DiabetesControlandComplicationsTrial(DCCT)international
standard.Secondarypatientreportedoutcomesincludeddiabetes
specific quality of life, patient enablement, perceptions of the
diabetes team, and self care.
25-30 (See supplementary table on
bmj.com for details of secondary outcomes.) Secondary carer
reportedoutcomesincludeddiabetesspecificqualityoflifeand
enablementandperceptionsofthediabetesteam.Parentreported
proxy measures (for children under 11 years) included diabetes
specificqualityoflifeandselfcare.Novelsingleitemmeasures
of clinic related affect (for example, feeling fed up, excited,
guilty,good,worried)werealsoincludedincarerandallpatient
questionnaires. Effective behaviour change can be viewed as
the combined effect of the importance attached to changing a
behaviour and the confidence of an individual to achieve such
change.
31 Therefore we developed two new six item scaled
measures of importance and confidence in managing diabetes
andevaluatedtheseforinclusionasoutcomesforolderchildren
(≥11 years) and carers.
At baseline, questionnaires were handed to families for
completion and returned direct to the trial team by post.
Follow-upquestionnairesweredispatchedandreturnedbypost
directly to the trial team. An interim questionnaire assessing
enablement was also completed at the first clinic visit after the
start of the trial. A case report form recording demographic and
clinical data (including hypoglycaemic episodes, body mass
index, and insulin regimen) was completed at baseline by the
research nurse from the young people’s notes. Clinical data
werecollectedateachsubsequentclinicvisituptoandincluding
the one year follow-up visit.
Sample size
An individually randomised trial would require 200 young
people to detect a moderate effect size of 0.4 for HbA1c at a 5%
significance level with 80% power. Assuming an intracluster
correlation coefficient of 0.08 (based on audit data from the
Wales Paediatric Diabetes Interest Group) and 24 centres
recruiting an average of 23 young people resulted in the sample
size being inflated to 550. Adjusting this to account for a 22%
loss to follow-up resulted in a target of 700 recruited young
people.Ofthe30centresinvited,fourdidnotparticipateowing
to a withdrawal of interest or inability to complete agreements
in time. The target number of centres was finally increased by
two (to 26) to allow for withdrawal of centres.
Statistical analysis
Theprimaryanalysiswasbyintentiontotreat,comparingHbA1c
values between study groups at one year follow-up. The
distribution of HbA1c data was positively skewed and a natural
logtransformationperformedforregressionanalysis.Multilevel
modelling was adjusted for cluster (centre) and individual
effects. Baseline levels of HbA1c were included as a covariate.
Primaryanalysisinvolvedatwolevellinearmodelandincluded
interactiontermsforbothageandsexwithtreatmentallocation.
The influence of missing data was examined by replacing
missing trial HbA1c values with routine clinic values where
possible. Analysis of secondary outcomes also used multilevel
modelling and incorporated baseline scores as covariates.
Variations in the skewness of outcome data were all within
limits of the methods used, and scores remained untransformed
formodelling.Nointerimanalyseswereplannedorundertaken.
Process evaluation
Theprocessevaluationfocusedontwosubstantivecomponents:
the adequacy of training delivery and fidelity to the menu of
guidingskillsandstrategies.Theadequacyoftraininginvolved
assessing level and quality of engagement by practitioners with
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RESEARCHthe training materials (access to online learning modules,
attendance at the two workshops, and provision of clinical case
feedback to trainers after training). The guiding skills and
strategiescomponentinvolvedratingasampleofaudiorecorded
clinical consultations across the trial sites. In addition,
representatives of each intervention arm clinical team were
interviewed by telephone at the end of the study period to
determinehowtheinterventionwasreceivedbyteams(including
factors that were seen to hinder or facilitate implementation),
and perceptions of the impact of training on practitioner
performance. Transcribed data from the semistructured
interviews were subject to coding and inductive analysis led by
one member of the research team (ETJ), with additional input
from two other experienced social researchers. The results of
the interview study are fully reported elsewhere, and are
summarised here.
20
Audio recording routine consultations enabled assessment of
the practitioners’ performance using an adapted measurement
scale.
19 20 Items assessed performance across five domains:
overall adherence to guiding style, agenda setting, and each of
the three consultation strategies (exploring the pros and cons
of change, importance and confidence about making changes,
and brainstorming). Items from an existing measure of
motivational interviewing practice were supplemented with
those dealing with intervention specific content.
32 Recordings
werecollectedfrominterventiongrouppractitionersimmediately
after training and at one year, and from control group
practitioners before training at the end of the one year study.
Practitioners were asked to record all consultations within a
single clinical session (where consent could be obtained) and
to nominate two consultations where a behaviour change issue
was discussed (although analysis could have included any
consultationinthatsession).Tocollectrecordingswerandomly
selected a maximum of three practitioners per clinic. Where
available, two consultations per practitioner were selected at
random for further analysis (two recordings per practitioner,
per time point for the intervention group). All recordings
selected were scored by a single trained rater and one in four
additionally rated by a second rater. Raters were blinded to
treatment allocation, based with the trial team, and unfamiliar
to the practitioners whose consultations were being assessed.
Where practitioner recordings were rated by two raters, κ
statistics were used to assess reliability and were between 0.49
and 0.88 for 10 of the 12 scales rated (indicating moderate to
excellent agreement) but lower for shared agenda setting use
and skilfulness (0.27 and 0.30, respectively).
Results
Twentysixcentresparticipatedandrecruited693youngpeople
with type 1 diabetes between August 2007 and January 2008
(figure⇓). Table 1⇓ shows the baseline characteristics of the
participants by study allocation. Although more intervention
centres than control centres reached their recruitment targets,
the characteristics were adequately balanced across arms,
includingHbA1clevels.Adjustingforsexintheprimaryanalysis
to account for the slight excess of boys in the intervention arm
did not alter the results. To reduce bias from knowledge of
allocation,recruitmentwasattemptedbeforerevealingthecentre
allocation and was achieved for 213 patients (30.7%). No
evidence of bias was found when baseline data were compared
between groups recruited before and after revealing treatment
allocation.
Seventy nine practitioners received training across the 13
intervention centres and reported enthusiasm for the training
package (including online and workshops).
20
Primary outcome
Baseline HbA1c measurements were obtained from 356/359
(99.2%) young people in the intervention arm and 333/334
(99.7%) in the control arm and from 342 (95.3%) and 318
(95.2%) respectively at follow-up. HbA1c levels increased in
both groups during the study period. The mean (SD) HbA1c for
the control group was 9.5 (1.7) and for the intervention group
was 9.7 (1.7) at follow-up. The intervention effect adjusted for
baseline HbA1c level (log transformed data) was 0.01 (95%
confidenceinterval−0.02to0.04,P=0.50,intraclasscorrelation
coefficient 0.057) and was not significant. Adding values from
routine clinic data for missing outcome data did not alter the
result (missing data were only evident for three young people
in the control group and seven in the intervention group). Sex
was significantly associated with HbA1c level at follow-up, but
adjusting for age and sex did not alter the results and no
significant interactions were evident between treatment
allocation and age or sex.
Patient and carer secondary outcomes
Overall, 390 young people (56%) and 441 carers (64%)
completed follow-up questionnaires at 12 months (figure).
Among the young people there was no intervention effect on
perceptions of the team providing healthcare (table 2⇓). Of the
quality of life subscales, the control group showed a small
improvement in problems with treatment barriers and a
borderlineimprovementinproblemswithtreatment,whichwas
not found for the intervention group (table 2). No other
differences were evident in standardised secondary outcomes
fortheyoungpeopleat12months(tables2and3⇓).Enablement
scores were higher for intervention patients in the short-term,
but this advantage was not sustained to 12 months (table 2).
Twosixitemmeasuresofimportanceandconfidenceindiabetes
self management developed for the study showed adequate
construct validity at baseline (factor analysis showing a single
factor solution in each case, and Cronbach’s α above 0.84 for
both patient and carer versions). No significant intervention
effect was found for either measure (table 2).
Among carers, there was no evidence of an intervention effect
on perceptions of the healthcare team, or on any of the quality
of life subscale scores (table 4⇓). A significant intervention
effect was found on perceptions of continuity of care with
improvements for the intervention group and deterioration for
the control group (table 4). Carers in the intervention group felt
more excited about prospective visits to the clinic (table 5⇓),
but no other differences were shown between the study groups
on the standardised or newly derived outcome measures (tables
4 and 5).
Safety of treatment and clinical outcomes
No reports of serious adverse events reported to the trial team
were judged to be related to the intervention. The intervention
had no effect on hypo episodes, body mass index, or insulin
regimen.
Process evaluation
Acrossthe13clinicalteamsintheinterventionarmofthestudy,
75 practitioners were eligible to be trained at study baseline. Of
these, 71 (94.7%) attended one or both of the workshops and
all logged onto the online training. After the start of the study
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RESEARCHperiod, a further four practitioners began working within one
of the 13 centres, and all made attempts to access the online
training at some point. The mean (SD) duration of time spent
logged onto the web site by each practitioner was 217 minutes
(137 minutes). After the second workshop, 43 practitioners
provided either partial or full reporting of clinical case data to
the training team for feedback.
In total, 170 valid recordings of consultations were obtained
(19 clinicians from 10 of the 13 intervention centres provided
data immediately after training, 30 clinicians from 13 of the 26
trial centres returned useable data at the one year follow-up).
At one year, the intervention group practitioners had better
scoresforguidingstyle(generalstyle,evocation,collaboration,
and autonomy-supportive) than did the control group
practitioners(table6⇓).Fortheinterventiongroup,guidingstyle
scores decreased over time, but this difference was only
significant for evocation (table 6). At one year, agenda setting
and brainstorming were more commonly observed in the
intervention group than were pros and cons or importance and
confidence (table 7⇓). The skilfulness by which these were
applied by intervention practitioners did not significantly alter
over time (table 8⇓).
The times patients and carers reported that they spent either
individually(parentonlyorchildonly)ortogetherwithvarious
health professionals at the clinic was recorded on case report
forms. The mean (SD) reported total time was 99.92 (56.30)
minutes for intervention clinics and 104.79 (69.60) minutes for
control clinics. The difference was not significant (P=0.32).
During the trial period, 11/334 (3.3%) young people in the
control arm did not attend the clinic at all compared with 4/359
(1.1%) in the intervention arm (difference 2.2, 95% confidence
interval −0.1 to 4.8). The mean (SD) number of clinic visits
was 3.5 (1.1) for participants in both the intervention and the
control arm. To investigate possible dose-effect, the number of
clinic visits was added to the multilevel model for the primary
outcome. The number of visits was not statistically significant
and the interaction between number of visits and trial arm was
not significant.
Eleven nurses, one dietitian, and one doctor from the
intervention centres were interviewed. Results of the main
interview analysis are reported elsewhere.
20 The following key
observations were, however, reported by interviewees. The
agenda setting tool was variably used by clinical teams, some
ofwhomsentitouttopatientsinadvanceofattendingtheclinic,
somemakingitavailableonarrivalorintheactualconsultation.
Respondents reported a reduction in use over time, perhaps
because issues may have already been raised and tackled in
previous consultations, although several teams reported
continuedattemptstousetheprincipleofasharedagendasetting
approach. Interviewees positively appraised the training and
valuedthewholeteamapproach.Facilitatorsofimplementation
included a physical aide memoire of the menu of strategies and
opportunities that were taken by some teams for team based
reflection. Barriers included the perceived time required to
practice and master intervention skills and time constraints
associated with busy clinics. However, many interviewees
reportedconfidenceintheirabilitytoimplementnewskillsover
time.Staffturnoverwasalsoreportedtobeabarriertoeffective
implementation. Despite such barriers, most interviewees
considered that consultations had shifted away from clinical
outcomes towards the needs of the child, facilitated by a
structured but open consultation with a less directive approach.
Manyfeltthattheirpractisehadchangedbutwithvariablelevels
of skilfulness.
Discussion
This multicentre, pragmatic trial evaluated the effectiveness of
a complex psychoeducational consulting skills intervention,
which aimed to enable all clinical members of paediatric
diabetes care teams to facilitate improved metabolic control in
their patients. We found that training paediatric teams in the
Talking Diabetes intervention did not improve glycaemic
control, had a negative impact on some aspects of quality of
life in the young people one year after practitioner training, but
had a short term beneficial effect on coping. The theory based
intervention was developed with a high level of stakeholder
input and included agenda setting and the flexible use of
consultation styles with a greater focus on the “guiding” style
along with other strategies drawn from motivational
interviewing,
33 and aimed to improve psychoeducational
consultationskillsandpracticeinallmembersofthecareteam.
Some benefits of the intervention on perceived continuity of
care and feeling excited about clinic visits were observed in
carers, but similar improvements were not seen in the children.
Whereas these represent secondary outcomes in this study, the
former findings are welcome given concerns expressed by
parents during intervention development about feeling
marginalised during clinic visits.
Strengths and weaknesses of the study
Intervention development included systematic review of
evidence supporting effective psychoeducational interventions
in managing childhood diabetes and incorporated viewpoints
of practitioners, children, and their families, including the view
that clinicians should give prominence to patient preferences
and enhance patient autonomy. Principles from motivational
interviewing, with a strong evidence base for influencing
behaviour change including within diabetes care, informed
consultation strategies.
9 11 34 Presentation of the evolving
intervention to a Stakeholder Advisory Group resulted in
important modifications, including the development of the
agenda setting tool.
18
The cluster trial design was appropriate to an evaluation of a
whole team consultation skills intervention where diffusion of
skills at a team level would have been welcomed. Once trained
innewconsultingskills,clinicianscannotswitchbetweenusing
them and not using them as would have been required with
individual patient randomisation. Also, the intervention sought
todeterminetheeffectofaconsultationskillsapproachdeployed
over time by a particular service, so that exposure to a trained
team was necessary each time patients consulted. The delivery
of the intervention in each centre by a number of practitioners
also reduced the possibility that outcomes were a consequence
of practitioner influences such as personality, independent of
training in the intervention. Ascertainment of the primary trial
outcome was virtually complete, ensuring that the study had
adequate power to detect a meaningful effect on glycaemic
control, and minimised risk of attrition bias.
Trialcentresweregeographicallyspreadandwerebalancedfor
list size in randomisation, providing good generalisability of
the results for young people with diabetes aged 4-16 years and
their carers in the United Kingdom. The low dropout rate and
spread of attendance noted (from zero to six visits during the
study period in both trial arms) also strengthens the study
findings.TherewasmoderatevariationinHbA1clevelsbetween
centresatfollow-up(intraclustercorrelationcoefficientof0.06),
whichislikelytoreflectacombinationofdemographic,clinical,
and therapeutic factors differing across sites. Centre and
individual level effect were accounted for in the multilevel
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RESEARCHmodelling analysis. We also investigated differential effects of
theinterventionfordifferingbaselineHbA1cvalues.
20However,
the relevant interaction term was non-significant suggesting
that the intervention effect did not vary by initial level of
glycaemic control.
Althoughthepractitionersskilllevelsaftertrainingweregreater
in the intervention centres than in the control centres, the
absolute levels achieved were disappointing when compared
with the theoretically derived scale endpoints (with average
scoresforthoserecentlytrainedjustbelowthescalemid-point).
A competency assessment for practitioners after training may
have ensured greater fidelity to the delivery of the intervention
but would have been difficult to implement. Furthermore,
performance diminished over time, suggesting that
reinforcement of training was required. Training aimed to
enhance consulting skills but not meaningfully increase the
duration of consultations. Coverage of trained practitioners by
consultation recordings was lower than expected, although was
much better at follow-up than at baseline for the intervention
group. This was the combined result of practical challenges of
collecting audio data in busy routine clinics, requirements for
adequately documented consent, technical difficulties in
capturing and transferring digital audio, and probably some
naturalreticenceofthepractitionersaboutbeingrecorded.This
could therefore have introduced some ascertainment bias into
the dataset, although the subsequent selection process for
analysissoughttominimiseanyfurtherselectionbias.Although
it is possible that the more confident and skilful practitioners
were also more likely to provide recordings and hence
over-estimate the training effect, evidence of such an effect is
still provided.
While the process evaluation confirmed no increase in
consultation length, a potentially negative consequence was
only brief exposure of child and family to trained clinicians
duringtheyearoffollow-up(generallythreetofourclinicvisits
per year with a total contact time with all practitioners of less
than an hour). This was typically less than in previous trials of
motivational interviewing and other psychoeducational
interventions. For example, in a study in 2007, mean contact
time was four sessions of about 45 minutes each, involving the
same practitioner and carried out independently from the
diabetes clinic.
9
Most of the practitioners initially identified within each
intervention arm team received some or all of the blended
training.Oncetrained,itprovedharderforthetrainerstodirectly
engagewithpractitionerstoreinforcegoodpracticeasplanned.
Changestoteamstaffovertimeprobablydecreasedthepotential
impact of training, and although web based training remained
available for the duration of the study, additional face to face
workshops were not usually feasible for incoming staff. Teams
varied in their approach to integrating the intervention within
their clinic setting and some showed considerable enthusiasm
and engagement in developing local ownership. Although the
research team and trainers provided generic guidance and tools
to support implementation, delivering a low resource
interventionthatcouldthusberolledoutmorebroadlyinroutine
clinics placed restrictions on what could have been otherwise
achieved.
The primary trial outcome was chosen as an objective global
indicator of disease management with established associations
with longer term complications. It also has strong clinical
validityforpractitioners,parents,andchildren.Itisnevertheless
a distal outcome for an intervention that is delivered to
practitionersandmediatedthroughclinicalconsultations,aiming
to change patients’ attitudes and behaviour. Furthermore, with
a consultation agenda that was shared between practitioner and
child,notallchangesinbehaviourthatmayhavebeendiscussed
would have been expected to have had either an immediate or
even a potential impact on glycaemic control. We therefore
placed some emphasis on the importance of quality of life as a
key secondary outcome in this trial, and expect that such
outcomes will increasingly feature as primary outcomes in the
future trials of similar interventions for complex behaviour
change.
Building on evidence that outcomes for young people with
diabetesarebetterwhereparentsremaininvolvedinanegotiated
manner in their child’s care, the training programme produced
an intervention that aimed to influence both the children and
theircarers.
35Itisofinterestthatparentsintheinterventionarm
reported greater continuity of care than those in the control arm
anddidnotreportreducedconfidenceintheirabilitytomanage
the illness as reported by their children. Parents may have
benefitted more from the intervention than their children and
might be better placed to provide ongoing support to their
children as a consequence of care by teams exposed to the
intervention.
Comparison with other studies
Systematic reviews of psychoeducational interventions in
childrenandadolescentswithdiabetesreportamodestbeneficial
effect on psychological and metabolic outcomes,
7 36 although
few interventions have targeted younger children.
12 A further
concern has been the lack of UK based studies, limited data on
costeffectiveness,andtheuseofdiabetesspecificinterventions,
which have been poorly described, all making replicability and
applicability difficult to assess.
7 8 Most interventions have been
multifaceted making it difficult to identify which aspects have
been most responsible for change. The studies included in the
review were often short term, underpowered, not pragmatic,
and with interventions delivered by specialists within teams
rather than by whole team approaches. It is possible that the
effect of the Talking Diabetes intervention will be seen on
metaboliccontrolinchildrenafteroneyear(thefollow-upperiod
inourstudy),andthatpsychosocialandqualityoflifeoutcomes
are more proximal effects. Some studies of motivational
interviewing in diabetes have found positive effects two years
after the start of the intervention (for example
9). However, the
intervention effect at two years described in the previous study
was preceded by a similar advantage at one year, unlike the
present study. This comparison therefore does not support a
search for longer term benefits of the Talking Diabetes
intervention.Itneverthelessremainspossiblethattheshortterm
benefit in coping and the longer term negative impact on health
related aspects of diabetes quality of life may indicate some
longertermimpactoftheintervention,butfurtherinvestigation
would be required into potential mechanisms.
Our study attempted to tackle these limitations by delivering a
theoreticallydriven,manualisedinterventionforusebyarange
ofpractitionersdealingwithawideagerangeofchildren,using
clearlydefinedtheoreticalprinciplesandstrategies,withpatient
related outcomes assessed one year after training practitioners.
Our study therefore differed from the efficacy study of
motivational interviewing in childhood diabetes in that it
involvedtrainingwholeteamstodelivertheinterventionwithin
routine clinical care rather than evaluating an intervention
delivered by a single specialist practitioner.
9 11 Furthermore, to
make the intervention broadly deliverable in a routine clinic
setting, its content was drawn from, but did not fully equate to,
motivational interviewing. The added value of incorporating
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skills and strategies remains undetermined.
Implications for research and practice
Although welcomed by practitioners, our findings suggest that
traininginpsychoeducationalconsultationskillsforwholeteams
does not improve glycaemic control in young people with
diabetes over one year. In the light of this new evidence
therefore,suchtraininginitscurrentformatshouldnotberolled
outintheUKNationalHealthService.Theeconomicevaluation
undertaken within the present study
20 compared whole team
training with no training but did not explore whether whole
team training was more cost effective than additional specialist
provision. While our finding of no effect on glycaemic control
suggeststhatthisisunlikelytobethecase,thescarcityoftrained
clinical psychologists in UK paediatric diabetes services
suggestsaneedforfurtherresearchtoexaminewhethermodified
versions of the training intervention—for example, by
incorporatingareflectivelisteningcomponent—couldimprove
its clinical and cost effectiveness.
37
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RESEARCHTables
Table 1| Baseline characteristics of participants (data provided by children and carer) by allocation group. Values are numbers (percentages)
unless stated otherwise
Overall Training programme Standard care Characteristics
Children
9.3 (1.8) (n=689) 9.4 (1.7) (n=356) 9.2 (1.8) (n=333) Mean (SD) HbA1c level (%)
HbA1c distribution:
76 (11) 33 (9) 43 (13) <7.5%
240 (35) 117 (33) 123 (37) 7.5-9%
373 (54) 206 (58) 167 (50) >9%
10.6 (2.8) 10.4 (2.8) (n=359) 10.7 (2.8) (n=334) Mean (SD) age (years)
6.0 (3.0) 5.7 (3.0) (n=255) 6.3 (3.0) (n=253) Mean (SD) age (years) at diagnosis
5.1 (2.7) 5.2 (2.8) (n=255) 5.0 (2.7) (n=253) Mean (SD) duration (years) of diabetes
342 (49) 187 (52) 155 (46) Boys
19.4 (3.2) 19.5 (3.2) (n=356) 19.2 (3.1) (n=329) Mean (SD) body mass index
Ethnicity:
521 (91) 262 (91) 259 (91) White British
12 (2) 5 (2) 7 (2) Other white
23 (4) 12 (4) 11 (4) Mixed
5 (1) 4 (1) 1 (<1) Black or black British
13 (2) 6 (2) 7 (2) Asian or Asian British
1 (<1) 0 (0) 1 (<1) Other
Carer providing data
572 (93) 286 (93) 286 (93) Carer status: mothers
570 (99) 286 (99) 284 (99) Usually attends clinic
565 (98) 281 (99) 284 (97) Provide majority of care
572 (70) 286 (69) 286 (71) Generally see same doctor at clinic
569 (91) 284 (93) 285 (89) Generally see same nurse at clinic
Socioeconomic class:
273 (57) 134 (54) 139 (54) Managerial and professional occupations
69 (14) 38 (15) 31 (12) Immediate occupations
49 (10) 23 (9) 26 (10) Small employers and own account workers
50 (10) 28 (11) 22 (9) Lower supervisory and technical occupations
67 (13) 27 (11) 40 (16) Semiroutine and routine occupations
Denominators vary owing to missing values (assumed to be missing at random).
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RESEARCHTable 2| Secondary outcomes for young people with type 1 diabetes according to allocation group. Values are means (standard deviations)
unless stated otherwise
Adjusted for baseline score Training programme
No
Standard care
Variables P value Intervention effect (95% CI) ICC (%) Follow-up Baseline Follow-up Baseline No
0.66 0.04 (−0.2 to 0.2) 10.1 4.0 (0.71) 4.0 (0.69) 164 4.0 (0.62) 4.1 (0.60) 182 Healthcare climate
Quality of life:
0.03 −4.6 (−8.5 to −0.6) 0.9 67.5 (21.2) 66.8 (22.0) 167 73.3 (18.2) 69.3 (19.6) 186 Barriers
0.60 −0.9 (−4.2 to 2.4) 3.3 55.3 (15.3) 54.4 (15.0) 167 57.2 (14.3) 56.5 (13.6) 185 Symptoms
0.05 −3.1 (−6.3 to −0.01) 0 76.8 (17.4) 76.4 (17.2) 166 80.6 (15.4) 77.9 (15.1) 183 Adherence
0.10 −3.4 (−7.4 to 0.7) 0 67.2 (23.2) 68.8 (23.8) 162 69.8 (20.2) 67.3 (22.0) 181 Worry
0.06 −5.4 (−11.1 to 0.3) 0.1 62.3 (26.9) 63.3 (26.9) 162 69.1 (22.2) 66.0 (23.8) 181 Communication
0.85 −0.02 (−0.3 to 0.2) 7.8 4.2 (0.76) 4.3 (0.72) 88 4.3 (0.66) 4.5 (0.52) 121 Diabetes continuity in
care
0.46 1.8 (−3.0 to 6.6) 0 38.9 (20.8) 35.0 (21.7) 89 36.4 (20.6) 33.6 (19.2) 123 Problem areas in
diabetes
0.81 0.2 (−0.13 to 0.17) 0 4.0 (0.69) 4.1 (0.62) 89 4.0 (0.67) 4.2 (0.66) 123 Importance
0.06 −0.2 (−0.4 to 0) 0 3.5 (0.77) 3.7 (0.70) 89 3.7 (0.72) 3.7 (0.73) 123 Confidence
0.72 0.03 (−0.12 to 0.18) 0 1.8 (0.60) 1.6 (0.46) 80 1.8 (0.66) 1.6 (0.53) 110 Care/mismanagement
Patient enablement:
0.04 10.4 (0.5 to 20.4) 6.4 30.1 (32.6) 28.5 (30.4) 83 19.7 (25.4) 28.0 (28.8) 116 Interim
0.34 −5.2 (−16.1 to 5.7) 9.0 21.3 (27.7) 28.4 (29.4) 88 26.4 (30.9) 29.1 (30.9) 122 12 months
ICC=intraclass correlation coefficient.
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RESEARCHTable 3| Secondary outcomes for young people with type 1 diabetes according to allocation group. Values are numbers (percentages)
unless stated otherwise
P value
Adjusted for baseline (reference group=standard
care) Training programme
No
Standard care
No Individual item scores Odds ratio (95% CI) ICC (%) Follow-up Baseline Follow-up Baseline
0.29 0.7 (0.39 to 1.32) 0 36 (43) 40 (48) 84 61 (52) 62 (51) 118 Check glucose >4 times a day
Experiencing emotion items*:
0.08 1.5 (0.95 to 2.42) 1.0 77 9 (47) 55 (34) 163 70 (39) 62 (35) 179 Fed up
0.09 1.6 (0.93 to 2.65) 0.5 54 (34) 64 (40) 161 42 (23) 59 (33) 180 Excited
0.18 1.6 (0.79 to 3.41) 0 20 (12) 16 (10) 161 16 (9) 23 (13) 177 Guilty
0.57 1.1 (0.71 to 1.86) 0 104 (64) 108 (67) 162 115 (64) 130 (72) 181 Good
0.19 1.4 (0.85 to 2.29) 6.4 56 (34) 64 (39) 165 47 (26) 61 (34) 179 Worried
0.77 1.07 (0.69 to 1.66) 0 83 (52) 85 (54) 159 93 (51) 99 (54) 183 Living with diabetes†:
0.24 0.74 (0.45 to 1.22) 0 106 (66) 107 (67) 161 134 (74) 135 (75) 181 General quality of life‡
0.84 0.96 (0.62 to 1.48) 0 72 (44) 70 (43) 163 83 (46) 85 (47) 180 Quality of life compared with last
year§
ICC=intraclass correlation coefficient.
*Reported “a little,” “quite a bit,” or “very much” in response to emotion item.
†Reported “much easier” or “easier” living with diabetes compared with last year.
‡Reported in general feeling “very happy” or “happy.”
§Reported being “happier” or “much happier” than last year.
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RESEARCHTable 4| Secondary outcomes for carers of young people with type 1 diabetes according to allocation group. Values are means (standard
deviations) unless stated otherwise
P value
Adjusted for baseline score Training programme
No
Standard care
No Variables Effect (95% CI) ICC (%) Follow-up Baseline Follow-up Baseline
0.13 0.1 (0 to 0.2) 3.0 4.3 (0.62) 4.2 (0.64) 202 4.2 (0.59) 4.3 (0.57) 209 Healthcare climate
Quality of life:
0.08 −2.9 (−6.1 to 0.4) 0 59.0 (20.2) 60.4 (18.7) 203 62.3 (17.5) 61.3 (17.5) 208 Barriers
0.36 −1.0 (−3.1 to 1.1) 0 57.1 (14.9) 56.1 (13.9) 202 60.0 (13.6) 58.9 (13.3) 209 Symptoms
0.35 −1.4 (−4.4 to 1.6) 0.6 73.2 (17.3) 73.9 (16.4) 203 75.0 (15.9) 74.9 (16.3) 208 Adherence
0.67 0.8 (−2.9 to 4.6) 0 51.9 (21.9) 50.9 (24.1) 201 52.9 (22.2) 54.6 (20.8) 205 Worry
0.46 −1.7 (−6.2 to 2.8) 0 64.4 (29.0) 63.7 (28.0) 199 67.7 (25.3) 66.8 (26.8) 204 Communication
0.01 0.2 (0.1 to 0.3) 0 4.4 (0.63) 4.3 (0.69) 203 4.2 (0.73) 4.4 (0.59) 208 Diabetes continuity of
care
0.55 −0.9 (−3.7 to 2.0) 3.0 45.2 (20.2) 45.6 (18.7) 203 43.0 (19.4) 41.4 (17.6) 209 Problem areas in
diabetes
0.61 0.02 (−0.1 to 0.1) 0 4.7 (0.41) 4.6 (0.41) 202 4.7 (0.40) 4.7 (0.42) 208 Importance
0.78 −0.02 (−0.1 to 0.1) 0 3.8 (0.73) 3.7 (0.74) 203 3.8 (0.76) 3.7 (0.66) 208 Confidence
0.87 −0.01 (−0.10 to 0.09) 0 1.6 (0.51) 1.5 (0.47) 183 1.6 (0.57) 1.5 (0.43) 186 Care/mismanagement
Enablement:
0.11 5.2 (−1.3 to 11.6) 3.0 23.5 (28.4) 25.1 (31.5) 190 16.3 (25.2) 18.3 (27.8) 209 Interim
0.27 4.4 (−3.5 to 12.3) 3.4 28.7 (35.4) 24.3 (32.5) 201 23.9 (32.1) 22.3 (29.7) 207 12 months
ICC=intraclass correlation coefficient.
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RESEARCHTable 5| Secondary outcomes for carers of young people with type 1 diabetes according to allocation group. Values are numbers (percentages)
unless stated otherwise
P value
(Reference group=control) Training programme
No
Standard care
No Individual item scores Odds ratio (95% CI) ICC (%) Follow-up Baseline Follow-up Baseline
0.37 0.25 (0.16 to 1.37) 1.5 103 (54) 104 (55) 191 129 (64) 132 (65) 202 Check glucose >4 times a day
Experiencing emotion items*:
0.63 1.13 (0.69 to 1.85) 0 60 (31) 51 (26) 195 59 (30) 55 (28) 200 Fed up
0.03 1.90 (1.05 to 3.43) 3.3 37 (20) 30 (16) 190 23 (12) 30 (15) 196 Excited
0.67 1.11 (0.68 to 1.83) 0 57 (30) 49 (26) 190 55 (28) 49 (25) 198 Guilty
0.44 1.19 (0.76 to 1.85) 2.7 124 (65) 133 (70) 191 120 (60) 132 (66) 200 Good
0.50 1.16 (0.75 to 1.79) 0 108 (56) 101 (52) 193 103 (52) 98 (49) 200 Worried
0.69 0.91 (0.57 to 1.45) 1.2 61 (30) 71 (35) 201 63 (31) 77 (37) 206 Living with diabetes†
0.06 0.65 (0.41 to 1.03) 1.4 104 (53) 130 (66) 197 121 (59) 126 (61) 207 General quality of life‡
0.97 1.01 (0.66 to 1.55) 2.4 49 (25) 66 (33) 198 51 (25) 51 (25) 207 Quality of life compared with last year§
ICC=intraclass correlation coefficient.
*Reported “a little,” “quite a bit,” or “very much” in response to emotion item.
†Reported “much easier” or “easier” living with diabetes compared with last year.
‡Reported in general feeling “very happy” or “happy.”
§Reported being “happier” or “much happier.”
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RESEARCHTable 6| Guiding style scores in intervention and control group at various time points. Values are means (standard deviations), medians,
unless stated otherwise
Difference in means (P value*) Standard care Training programme
Scale
Before training at end
of one year (n=29)
One year after
training (n=29)
Immediately after
training (n=28)
One year after
training−before training
One year after
training−immediately after
training
1.14 (<0.001) −0.33 (0.128) 1.2 (0.47), 1 2.3 (0.85), 2 2.6 (0.91), 3 Guiding style
0.90 (<0.001) −0.61 (0.039) 1.1 (0.44), 1 2.0 (1.02), 2 2.6 (1.06), 3 Evocation
0.83 (<0.001) −0.30 (0.188) 1.5 (0.63), 1 2.3 (0.84), 2 2.6 (0.92), 3 Collaboration
1.07 (<0.001) −0.26 (0.171) 1.3 (0.60), 1 2.4 (0.82), 3 2.6 (0.83), 3 Autonomy-supportive
*Mann-Whitney U test.
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RESEARCHTable 7| Proportion of control and intervention groups with task done or partially done at one year. Values are numbers (percentages)
unless stated otherwise
Difference in proportions (95% CI) Standard care Training programme
Task
One year after training−before
training at end of one year
One year after
training−immediately after
training
Before training at end
of one year (n=29)
One year after
training (n=29)
Immediately after
training (n=28)
0.45 (0.22 to 0.62) −0.20 (−0.42 to 0.05) 2 (6.9) 15 (51.7) 20 (71.4) Shared agenda
setting
0.10 (−0.03 to 0.26) −0.18 (−0.38 to 0.03) 0 (0.0) 3 (10.3) 8 (28.6) Pros and cons
0.10 (−0.03 to 0.26) −0.11 (−0.30 to 0.08) 0 (0.0) 3 (10.3) 6 (21.4) Importance and
confidence
0.21 (0.03 to 0.39) −0.33 (−0.53 to −0.08) 1 (3.5) 7 (24.1) 16 (57.1) Brainstorming
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RESEARCHTable 8| Skilfulness scores in intervention group practitioners immediately after training and at one year after training. Values are means
(standard deviations), medians, unless stated otherwise
Difference in means (one year after training−immediately after
training) (P value*)
Training programme
Skilfulness One year after training No Immediately after training No
−0.23 (0.44) 2.3 (0.80), 2 15 2.5 (0.89), 2 20 Shared agenda setting
−1.46 (0.05) 1.7 (0.58), 2 3 3.1 (1.13), 3 8 Pros and cons
−0.50 (0.58) 1.7 (0.58), 2 3 2.2 (1.17), 2 6 Importance and confidence
0.13 (0.64) 2.6 (0.54), 3 7 2.4 (0.89), 2 16 Brainstorming
*Mann-Whitney U test.
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RESEARCHFigure
Flow of participants through study
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RESEARCH